SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,586.00    0.00 (0.00%)
Bid:
4,568.00
Ask:
4,572.00
Spread: 4.00 (0.088%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

19 Mar 2025 13:30

RNS Number : 3419B
Coca-Cola HBC AG
19 March 2025
 

FOR IMMEDIATE RELEASE

19 March 2025

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified of the following holding restructuring by a legal person closely associated ('PCA') with a PDMR.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

MERVAIL COMPANY (ptc) ltD

2

 

Reason for the notification

a)

 

Position/status

 

PCA OF ANASTASIOS LEVENTIS, DIRECTOR AND PDMR

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

ACQUISITION OF 757,306 SHARES BY MERVAIL COMPANY (PTC) LTD, AS TRUSTEE OF A PRIVATE DISCRETIONARY TRUST FOR THE PRIMARY BENEFIT OF PRESENT AND FUTURE MEMBERS OF THE FAMILY OF THE LATE AVGIE LEVENTIS (WHICH INCLUDES THE PDMR) PURSUANT TO AN INTERNAL REORGANISATION RELATING TO 2,138,277 SHARES HELD DIRECTLY BY CARLCAN HOLDING LTD IN THE ISSUER.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

0,00 GBP

757,306

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

0.00 GBP

757,306

0,00 GBP

e)

 

Date of the transaction

 

2025-03-19

 

f)

 

Place of the transaction

 

OUTSIDE OF TRADING VENUE

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKCBBNBKDCND
Date   Source Headline
27th Dec 20237:04 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20235:35 pmRNSTransaction in Own Shares
21st Dec 20232:49 pmRNSDirector/PDMR Shareholding
20th Dec 20235:20 pmRNSTransaction in Own Shares
20th Dec 20237:15 amRNSTransaction in Own Shares
19th Dec 202312:50 pmRNSPublication of a Prospectus
19th Dec 202312:22 pmRNSDirector/PDMR Shareholding
19th Dec 20237:15 amRNSTransaction in Own Shares
15th Dec 20235:50 pmRNSTransaction in Own Shares
14th Dec 20235:45 pmRNSTransaction in Own Shares
14th Dec 20237:15 amRNSTransaction in Own Shares
13th Dec 20237:15 amRNSTransaction in Own Shares
12th Dec 20237:15 amRNSTransaction in Own Shares
11th Dec 20237:15 amRNSTransaction in Own Shares
8th Dec 20237:15 amRNSTransaction in Own Shares
7th Dec 20237:15 amRNSTransaction in Own Shares
6th Dec 20237:15 amRNSTransaction in Own Shares
5th Dec 20237:15 amRNSTransaction in Own Shares
4th Dec 20237:15 amRNSTransaction in Own Shares
1st Dec 20232:48 pmRNSDirector/PDMR Shareholding
1st Dec 20239:44 amRNSIssue of equity and total voting rights
1st Dec 20237:15 amRNSTransaction in Own Shares
30th Nov 20237:15 amRNSTransaction in Own Shares
29th Nov 20237:20 amRNSTransaction in Own Shares
28th Nov 20237:15 amRNSTransaction in Own Shares
27th Nov 20237:15 amRNSTransaction in Own Shares
24th Nov 20237:15 amRNSTransaction in Own Shares
23rd Nov 20237:15 amRNSTransaction in Own Shares
22nd Nov 202312:44 pmRNSREPLACEMENT - Transaction in Own Shares
22nd Nov 20237:15 amRNSTransaction in Own Shares
20th Nov 20234:45 pmRNSCommencement of share purchase programme
20th Nov 20234:12 pmRNSDirector/PDMR Shareholding
20th Nov 20233:29 pmRNSDirector/PDMR Shareholding
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights
21st Sep 202311:01 amRNSDirector/PDMR Shareholding
19th Sep 20231:02 pmRNSDirector/PDMR Shareholding
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.